购物车
全部删除
您的购物车当前为空
EGFR-IN-162 (compound 20) 是一种高效的EGFR抑制剂,能够增强早期和晚期凋亡 (EGFR) 以及坏死 (necrosis)。该化合物在乳腺癌研究中显示出潜在应用价值。
EGFR-IN-162 (compound 20) 是一种高效的EGFR抑制剂,能够增强早期和晚期凋亡 (EGFR) 以及坏死 (necrosis)。该化合物在乳腺癌研究中显示出潜在应用价值。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
EGFR-IN-162 相关产品
| 产品描述 | EGFR-IN-162 (compound 20) is an effective EGFR inhibitor that enhances both early and late apoptosis (EGFR) as well as necrosis (necrosis). It shows potential for use in breast cancer research. |
| 分子式 | C27H31N3O2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容